Robert J. Flanagan, Director at Sagent Pharmaceuticals, Inc. (SGNT), sold 16,000 shares at $31.96 ($505K) on 2014-10-08, disclosed to the SEC on 2014-10-08.
Scheduled sale ($505k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.15 | 8,000 | $249K | 49.4% |
| 2 | $31.96 | 8,000 | $256K | 50.6% |
| Total | $31.55 avg | 16,000 | $505K | 100% |
| Filing → |
| SGNT | SELL | 2014-09-25 | $480K | — | Filing → |
| SGNT | SELL | 2014-09-12 | $453K | — | Filing → |
| SGNT | SELL | 2014-08-29 | $435K | — | Filing → |